Cantor Fitzgerald’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-50,000
Closed -$38.1M 301
2025
Q3
$38.1M Buy
+50,000
New +$37.2M 0.37% 52

Other funds holding LLY

Cantor Fitzgerald's LLY Position: Q1 2026 in Review

Cantor Fitzgerald increased its Eli Lilly (LLY) stake by 41% in Q1 2026, buying an estimated $5.36M and bringing the position to 18,137 shares worth $16.7M. The position accounts for 0.25% of the portfolio, ranked #59.

Cantor Fitzgerald first reported a position in LLY in Q1 2022 and has held it in 14 quarters since. The position peaked at $50.3M in Q3 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Cantor Fitzgerald held 18,137 shares of Eli Lilly worth $16.7M as of Q1 2026.
  • Cantor Fitzgerald bought 5,288 Eli Lilly shares in Q1 2026, an estimated $5.36M.
  • Eli Lilly made up 0.25% of Cantor Fitzgerald's portfolio in Q1 2026, its #59 holding.
  • Cantor Fitzgerald first reported a position in Eli Lilly in Q1 2022 and has held it in 14 quarters since.
  • Cantor Fitzgerald's Eli Lilly position peaked at $50.3M in Q3 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Cantor Fitzgerald's 13F filing for Q1 2026, filed 15 May 2026.